Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Vivozon Pharmaceutical Co Ltd
Unrealized Security Profit/Loss
Vivozon Pharmaceutical Co Ltd
Unrealized Security Profit/Loss Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Unrealized Security Profit/Loss | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
|
Unrealized Security Profit/Loss
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SK Hynix Inc
KRX:000660
|
Unrealized Security Profit/Loss
₩252.1B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
63%
|
|
|
DB HiTek Co Ltd
KRX:000990
|
Unrealized Security Profit/Loss
-₩1.7B
|
CAGR 3-Years
55%
|
CAGR 5-Years
39%
|
CAGR 10-Years
15%
|
|
|
H
|
Hana Micron Inc
KOSDAQ:067310
|
Unrealized Security Profit/Loss
₩23.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
|
L
|
Leeno Industrial Inc
KOSDAQ:058470
|
Unrealized Security Profit/Loss
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
F
|
Fadu Inc
KOSDAQ:440110
|
Unrealized Security Profit/Loss
-₩4.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vivozon Pharmaceutical Co Ltd
Glance View
Vivozon Pharmaceutical Co., Ltd. engages in the manufacture and sale of compound semiconductors. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2005-11-18. The firm operates its business through three segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of finished medicines such as external skin preparations, antipyretic analgesic, anti-inflammatory drugs and antidiabetic drugs. The Optical Business segment is engaged in the manufacture and sale of finished products and lighting module sets such as general lighting and automotive lighting using light emitting diode (LED) light sources. The Cosmetics Business segment is engaged in the manufacture and sale of cosmetics and cosmetic ingredients.
